Predicting Genetic Variants that Alter 3D Genome Folding in Cancer and Developmental Disorders
OnlineUsing deep learning models of 3D chromatin interactions, driven solely by DNA sequence, to interpret disease-associated genetic variants.
Using deep learning models of 3D chromatin interactions, driven solely by DNA sequence, to interpret disease-associated genetic variants.
Join the NIH for a Neuroscience Seminar Series session titled “Building our brains: From development to evolution.”
Explore how USP public standards enhance drug quality, simplify product development, and facilitate regulatory compliance.
Explore human subjects protections and other considerations at the core of ethical research relationships related to focus groups.
The HCCA is offering a virtual workshop focused on the fundamentals and advanced practices of risk assessment.
Join The Society of Research Administrators International (SRAI) on December 16 from 2 p.m. to 3 p.m. for their webinar on research development.
The FDA will host the "Cheminformatics Resources of U.S. Governmental Organizations 2026 Workshop" from January 5–7, 2026.
NIH to host a presentation on "Insights and Practical Considerations for Communicating Basic Science," the capstone report of the SciPEP initiative.
This webinar provides strategies for translating the regulatory requirements of 45 CFR 46, Subpart D into actionable procedures for field research.
Join The NIH Office of Technology Transfer (OTT) for a presentation covering a number of technology transfer activities.
NIST has released a new small business primer for SP 800-171, Revision 3, designed to help small and medium-sized businesses understand and apply the requirements...
This NIH webinar series will present six sessions examining the critical intersection of neuroscience and cancer biology.
Join the NIH session on "Retrotransposons and Retroviruses; DNA on the Move" as part of a seminar series that shares research in biomedical fields.
The NIH is hosting a hybrid workshop that dives into new research regarding the future of HCT and gene therapy for sickle cell disease.